FY2021
Bankan maiden Resource followed year-end
The maiden 3.65Moz Bankan Mineral Resource was announced on 30 September 2021, after the 30 June balance date; two FY2021 placements raised A$37.1m before costs.
ASX: PDI · Five-year financial review
Predictive Discovery Limited (ASX: PDI) - Five-Year Financial Review FY2021-FY2025
A five-year view of an exploration and development company: statutory losses, cash use, equity funding and Bankan project estimates. Financial statements are in Australian dollars (A$); Bankan study economics are in US dollars and are prospective project estimates.
Reading the tables: 0 (nil) is a supported zero. Other text distinguishes an amount included in another line, a non-applicable item, a separately unavailable component and an unresolved value. These are not interchangeable. Period-specific detail is labelled; complete year-by-year detail remains available.
FY2025 cash
A$41.2m
Cash and cash equivalents at 30 June 2025; other financial assets are separate.
FY2025 capitalised exploration
A$159.6m
Consolidated balance-sheet carrying amount.
FY2025 net financing cash
A$67.9m
Includes share issue costs and lease payments.
Bankan DFS
US$463m
Estimated pre-production capital, not incurred capital expenditure.
Five years in context
Predictive Discovery advanced Bankan in Guinea from a maiden Mineral Resource announced after the FY2021 balance date to a June 2025 Definitive Feasibility Study. The company remained in exploration and development through this review window; its income statement reports losses and finance income, without a gold-sales revenue line. The financial statements use Australian dollars.
Equity issues funded exploration and project development. Cash-flow presentation changed in FY2024: exploration payments appear in operating activities through FY2023 and in investing activities in FY2024-FY2025. The operating-cash-flow series should be read with that classification break in mind.
Events behind the numbers
FY2022
Capital for drilling
An institutional placement was completed in May 2022; the later August 2022 Bankan Resource update is shown by its own date in the project table.
FY2023
Resource definition and equity raise
The June 2023 equity raise supported regional exploration. An August 2023 Resource estimate followed the financial year-end.
FY2024
PFS and maiden Ore Reserve
The April 2024 PFS outlined a proposed 12-year operation and maiden approximately 3.05Moz Probable Ore Reserve; the project figures are study estimates.
FY2025
ESIA approval and DFS
Guinea approved the ESIA and issued an Environmental Compliance Certificate in January 2025. The June DFS estimated US$463m pre-production capital and 2.95Moz Ore Reserves.
FINANCIAL REVIEW / 01
Statutory performance
The group reported a statutory loss in each year. The FY2023 original-year continuing-operations figure is shown on its own reporting basis; the FY2024 report subsequently presented an FY2023 discontinued-operation comparative. These bases should not be silently joined.
Exploration before obtaining tenure was expensed, while qualifying exploration and evaluation costs were capitalised on the balance sheet. Share-based payments and Guinea indirect taxes also affected the reported result.
Continuing-operations result
A$
Loss from continuing operations
AI-generated presentation · values from Consolidated profit or loss - continuing operations; no missing values plotted as zero.
Basic loss per share
cents per share
Basic loss per share
AI-generated presentation · values from Annual result, comprehensive loss and basic EPS; no missing values plotted as zero.
Consolidated profit or loss - continuing operations
A$ unless a row specifies another unit
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Finance incomeA$ | 4,865 | 3,113 | 632,838 | 1,565,567 | 2,169,759 |
| Other incomeA$ | 15,037 | 0 (nil) | 0 (nil) | 170,767 | 0 (nil) |
| Share based paymentsA$ | (1,093,054) | (731,130) | (3,880,848) | (2,066,283) | (4,968,139) |
| Administrative expensesA$ | (1,132,892) | (1,544,165) | (1,785,873) | (1,696,546) | (3,076,237) |
| Depreciation of fixed assetsA$ | (60,529) | (221,747) | (379,971) | (445,270) | (456,958) |
| Depreciation – right-of-use assetsA$ | Not separately presented | 0 (nil) | (144,085) | (144,194) | (146,578) |
| Loss on disposal of fixed assetsA$ | Not separately presented | 0 (nil) | (6,528) | (264) | (1,033) |
| Foreign exchange gain/(loss)A$ | 86,126 | 313,645 | (506,264) | 115,714 | 89,863 |
| Employee benefits expenseA$ | (518,329) | (309,962) | (352,262) | (487,887) | (382,407) |
| Provision for doubtful debts (FY2021 label)A$ | (426,580) | Not separately presented | Not separately presented | Not separately presented | Not separately presented |
| FY2021 gain on acquisition of exploration assetA$ | 683 | Not applicable | Not applicable | Not applicable | Not applicable |
| Impairment of receivables / VAT expense (issuer labels)A$ | Not separately presented | (918,837) | (2,521,633) | (1,450,793) | (2,134,594) |
| Indirect foreign taxes (Guinea)A$ | Not separately presented | (1,682,894) | 950,527 | (467,609) | (53,852) |
| Exploration expenditure pre-right to tenureA$ | (1,005,499) | (2,584,362) | (2,951,818) | (3,512,817) | (4,331,998) |
| Cost to dispose of subsidiaries (FY2023 original basis)A$ | Not separately presented | 0 (nil) | (285,406) | Not applicable | Not applicable |
| Impairment / write-off of exploration expenditureA$ | (2,492,232) | (2,011,363) | 0 (nil) | (254,496) | 0 (nil) |
| Revaluation of investment – listed company sharesA$ | Not separately presented | Not separately presented | Not separately presented | 6,180 | 290,450 |
| Loss before income tax (continuing)A$ | (6,622,404) | (9,687,702) | (11,231,323) | (8,667,931) | (13,001,724) |
| Income tax expenseA$ | 0 (nil) | 0 (nil) | 0 (nil) | 0 (nil) | 0 (nil) |
| Loss from continuing operationsA$ | (6,622,404) | (9,687,702) | (11,231,323) | (8,667,931) | (13,001,724) |
Reported dollar amounts with expenses and losses shown as negative. FY2023 uses the FY2023 original-year statement; later comparatives may be reclassified.
A source-supported nil is displayed as 0 (nil) only for the matching metric and period. An absent line remains not separately presented rather than zero.
FY2021 doubtful-debt provision and FY2022 impairment of receivables/FY2023-onward VAT expense have changing issuer labels; their original line positions are preserved.
FY2023 original statement included A$285,406 cost to dispose of subsidiaries above its continuing-operation loss. The FY2024 report subsequently moved that amount into discontinued operations in its FY2023 comparative.
The A$683 gain on acquisition of an exploration asset is a FY2021 transaction (R000385); its later coordinates are not applicable to that event. FY2023 subsidiary-disposal cost is retained on its original-year basis and is not repeated in FY2024–FY2025.
Basis and presentation notes (31)
- Other income / FY2022 — 0 (nil): Issuer reported a dash or nil for this line.
- Other income / FY2023 — 0 (nil): Issuer reported a dash or nil for this line.
- Other income / FY2025 — 0 (nil): Issuer reported a dash or nil for this line.
- Depreciation – right-of-use assets / FY2021 — Not separately presented: Depreciation – right-of-use assets is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R001956 supports a distinct FY2023 observation, not this target period.
- Depreciation – right-of-use assets / FY2022 — 0 (nil): Issuer reported a dash or nil for this line.
- Loss on disposal of fixed assets / FY2021 — Not separately presented: Loss on disposal of fixed assets is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R001958 supports a distinct FY2023 observation, not this target period.
- Loss on disposal of fixed assets / FY2022 — 0 (nil): Issuer reported a dash or nil for this line.
- Provision for doubtful debts (FY2021 label) / FY2022 — Not separately presented: Provision for doubtful debts (FY2021 label) is not separately resolved in the selected FY2022 statement. No nil value or issuer non-disclosure is inferred. R000381 supports a distinct FY2021 observation, not this target period.
- Provision for doubtful debts (FY2021 label) / FY2023 — Not separately presented: Provision for doubtful debts (FY2021 label) is not separately resolved in the selected FY2023 statement. No nil value or issuer non-disclosure is inferred. R000381 supports a distinct FY2021 observation, not this target period.
- Provision for doubtful debts (FY2021 label) / FY2024 — Not separately presented: Provision for doubtful debts (FY2021 label) is not separately resolved in the selected FY2024 statement. No nil value or issuer non-disclosure is inferred. R000381 supports a distinct FY2021 observation, not this target period.
- Provision for doubtful debts (FY2021 label) / FY2025 — Not separately presented: Provision for doubtful debts (FY2021 label) is not separately resolved in the selected FY2025 statement. No nil value or issuer non-disclosure is inferred. R000381 supports a distinct FY2021 observation, not this target period.
- FY2021 gain on acquisition of exploration asset / FY2022 — Not applicable: This row is the FY2021 exploration-asset acquisition gain of A$683 (R000385), not a FY2022 transaction. No FY2022 amount is imputed.
- FY2021 gain on acquisition of exploration asset / FY2023 — Not applicable: This row is the FY2021 exploration-asset acquisition gain of A$683 (R000385), not a FY2023 transaction. No FY2023 amount is imputed.
- FY2021 gain on acquisition of exploration asset / FY2024 — Not applicable: This row is the FY2021 exploration-asset acquisition gain of A$683 (R000385), not a FY2024 transaction. No FY2024 amount is imputed.
- FY2021 gain on acquisition of exploration asset / FY2025 — Not applicable: This row is the FY2021 exploration-asset acquisition gain of A$683 (R000385), not a FY2025 transaction. No FY2025 amount is imputed.
- Impairment of receivables / VAT expense (issuer labels) / FY2021 — Not separately presented: Impairment of receivables / VAT expense (issuer labels) is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R001069 supports a distinct FY2022 observation, not this target period.
- Indirect foreign taxes (Guinea) / FY2021 — Not separately presented: Indirect foreign taxes (Guinea) is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R001071 supports a distinct FY2022 observation, not this target period.
- Cost to dispose of subsidiaries (FY2023 original basis) / FY2021 — Not separately presented: Cost to dispose of subsidiaries (FY2023 original basis) is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R001968 supports a distinct FY2023 observation, not this target period.
- Cost to dispose of subsidiaries (FY2023 original basis) / FY2022 — 0 (nil): Issuer reported a dash or nil for this line.
- Cost to dispose of subsidiaries (FY2023 original basis) / FY2024 — Not applicable: The A$285,406 line is the FY2023 original-year cost to dispose of subsidiaries (R001968). The later statements present discontinued operations on their own basis; this FY2023-specific original-basis row is not a FY2024 observation.
- Cost to dispose of subsidiaries (FY2023 original basis) / FY2025 — Not applicable: The A$285,406 line is the FY2023 original-year cost to dispose of subsidiaries (R001968). The later statements present discontinued operations on their own basis; this FY2023-specific original-basis row is not a FY2025 observation.
- Impairment / write-off of exploration expenditure / FY2023 — 0 (nil): Issuer reported a dash or nil for this line.
- Impairment / write-off of exploration expenditure / FY2025 — 0 (nil): FY2025 Note 9/source R004322 labels this as exploration expenditure written off, nil. Earlier years use the issuer impairment wording; the slash label preserves this wording change.
- Revaluation of investment – listed company shares / FY2021 — Not separately presented: Revaluation of investment – listed company shares is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R002969 supports a distinct FY2024 observation, not this target period.
- Revaluation of investment – listed company shares / FY2022 — Not separately presented: Revaluation of investment – listed company shares is not separately resolved in the selected FY2022 statement. No nil value or issuer non-disclosure is inferred. R002969 supports a distinct FY2024 observation, not this target period.
- Revaluation of investment – listed company shares / FY2023 — Not separately presented: Revaluation of investment – listed company shares is not separately resolved in the selected FY2023 statement. No nil value or issuer non-disclosure is inferred. R002969 supports a distinct FY2024 observation, not this target period.
- Income tax expense / FY2021 — 0 (nil): Issuer reported a dash or nil for this line.
- Income tax expense / FY2022 — 0 (nil): Issuer reported a dash or nil for this line.
- Income tax expense / FY2023 — 0 (nil): Issuer reported a dash or nil for this line.
- Income tax expense / FY2024 — 0 (nil): Issuer reported a dash or nil for this line.
- Income tax expense / FY2025 — 0 (nil): Issuer reported a dash or nil for this line.
Source: Predictive Discovery annual reports for the stated years; each cell retains its frozen extraction or selected table row in the author evidence.
Annual result, comprehensive loss and basic EPS
A$ except EPS in cents/share
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Discontinued-operation loss (FY2023 later comparative)A$ | Not separately presented | Not separately presented | (285,406) | (6,940) | 0 (nil) |
| Loss for the yearA$ | (6,622,404) | (9,687,702) | (11,231,323) | (8,674,871) | (13,001,724) |
| Exchange difference on translation of foreign operations (OCI)A$ | 948 | 4,025,911 | 1,001,760 | (1,317,964) | (1,313,515) |
| Total comprehensive loss for the yearA$ | (6,621,456) | (5,661,791) | (10,229,563) | (9,992,835) | (14,315,239) |
| Basic loss per sharecents per share | (0.700) | (0.700) | (0.600) | (0.400) | (0.53) |
FY2025 EPS is disclosed in the issuer narrative at (0.53) cents, versus (0.41) cents for its FY2024 comparative; earlier displayed EPS is rounded as printed in each original-year statement.
The FY2024 report reclassified A$285,406 of FY2023 loss as discontinued. That single cell is the later comparative and cannot be added to the FY2023 original-year continuing loss shown above; total FY2023 loss is unchanged.
Basis and presentation notes (3)
- Discontinued-operation loss (FY2023 later comparative) / FY2021 — Not separately presented: Discontinued-operation loss (FY2023 later comparative) is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R002979 supports a distinct FY2023 observation, not this target period.
- Discontinued-operation loss (FY2023 later comparative) / FY2022 — Not separately presented: Discontinued-operation loss (FY2023 later comparative) is not separately resolved in the selected FY2022 statement. No nil value or issuer non-disclosure is inferred. R002979 supports a distinct FY2023 observation, not this target period.
- Discontinued-operation loss (FY2023 later comparative) / FY2025 — 0 (nil): Issuer reported a dash or nil for this line.
Source: Predictive Discovery annual reports for the stated years; each cell retains its frozen extraction or selected table row in the author evidence.
FINANCIAL REVIEW / 02
Financial position
Capitalised exploration and evaluation expenditure grew as Bankan work advanced. Term deposits held for more than 90 days are reported separately from cash and cash equivalents in FY2024 and FY2025.
The group reported no balance-date borrowings in each annual description. The FY2024 balance sheet separately presented an A$1.5m advance from an FX provider, settled shortly after year-end. Issued capital in the consolidated balance sheet and the gross share-capital movement schedule use different cost presentations.
Cash and cash equivalents
A$
Cash and cash equivalents
AI-generated presentation · values from Consolidated current assets; no missing values plotted as zero.
Capitalised exploration
A$
Exploration and evaluation expenditure (capitalised)
AI-generated presentation · values from Consolidated non-current assets and total assets; no missing values plotted as zero.
Consolidated current assets
A$ unless a row specifies another unit
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalentsA$ | 22,729,169 | 42,035,541 | 44,894,558 | 29,434,172 | 41,210,041 |
| Other financial assets - term deposits (>90 days)A$ | Not separately presented | Not separately presented | 0 (nil) | 23,000,000 | 28,020,000 |
| Trade and other receivablesA$ | 232,836 | 404,150 | 500,985 | 1,142,515 | 1,306,319 |
| InventoryA$ | Not separately presented | Not separately presented | Not separately presented | 0 (nil) | 262,090 |
| Total current assetsA$ | 22,962,005 | 42,439,691 | 45,395,543 | 53,576,687 | 70,798,450 |
Basis and presentation notes (7)
- Other financial assets - term deposits (>90 days) / FY2021 — Not separately presented: Other financial assets - term deposits (>90 days) is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R002825 supports a distinct FY2024 observation, not this target period.
- Other financial assets - term deposits (>90 days) / FY2022 — Not separately presented: Other financial assets - term deposits (>90 days) is not separately resolved in the selected FY2022 statement. No nil value or issuer non-disclosure is inferred. R002825 supports a distinct FY2024 observation, not this target period.
- Other financial assets - term deposits (>90 days) / FY2023 — 0 (nil): Issuer reported a dash or nil for this line.
- Inventory / FY2021 — Not separately presented: Inventory is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R003892 supports a distinct FY2025 observation, not this target period.
- Inventory / FY2022 — Not separately presented: Inventory is not separately resolved in the selected FY2022 statement. No nil value or issuer non-disclosure is inferred. R003892 supports a distinct FY2025 observation, not this target period.
- Inventory / FY2023 — Not separately presented: Inventory is not separately resolved in the selected FY2023 statement. No nil value or issuer non-disclosure is inferred. R003892 supports a distinct FY2025 observation, not this target period.
- Inventory / FY2024 — 0 (nil): Issuer reported a dash or nil for this line.
Source: Predictive Discovery annual reports for the stated years; each cell retains its frozen extraction or selected table row in the author evidence.
Consolidated non-current assets and total assets
A$ unless a row specifies another unit
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Property, plant and equipmentA$ | 321,176 | 811,526 | 878,692 | 579,766 | 517,212 |
| Exploration and evaluation expenditure (capitalised)A$ | 15,505,090 | 37,376,965 | 87,201,892 | 122,141,747 | 159,565,524 |
| Right of use assetsA$ | Not separately presented | 0 (nil) | 312,188 | 168,230 | 24,236 |
| Investment in listed companyA$ | Not separately presented | Not separately presented | Not separately presented | 123,596 | 414,046 |
| Total non-current assetsA$ | 15,826,266 | 38,188,491 | 88,392,772 | 123,013,339 | 160,521,018 |
| Total assetsA$ | 38,788,271 | 80,628,182 | 133,788,315 | 176,590,026 | 231,319,468 |
The FY2021 nil investments-in-associates line is not treated as evidence of a later listed-company holding.
Basis and presentation notes (5)
- Right of use assets / FY2021 — Not separately presented: Right of use assets is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R001848 supports a distinct FY2023 observation, not this target period.
- Right of use assets / FY2022 — 0 (nil): Issuer reported a dash or nil for this line.
- Investment in listed company / FY2021 — Not separately presented: Investment in listed company is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R002837 supports a distinct FY2024 observation, not this target period.
- Investment in listed company / FY2022 — Not separately presented: Investment in listed company is not separately resolved in the selected FY2022 statement. No nil value or issuer non-disclosure is inferred. R002837 supports a distinct FY2024 observation, not this target period.
- Investment in listed company / FY2023 — Not separately presented: Investment in listed company is not separately resolved in the selected FY2023 statement. No nil value or issuer non-disclosure is inferred. R002837 supports a distinct FY2024 observation, not this target period.
Source: Predictive Discovery annual reports for the stated years; each cell retains its frozen extraction or selected table row in the author evidence.
Consolidated liabilities and equity
A$ unless a row specifies another unit
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Trade and other payablesA$ | 2,496,890 | 6,548,463 | 4,631,848 | 4,984,759 | 2,682,205 |
| Right of use liabilities (current)A$ | Not separately presented | 0 (nil) | 313,241 | 159,327 | 0 (nil) |
| Advance from FX providerA$ | Not separately presented | Not separately presented | Not separately presented | 1,500,000 | 0 (nil) |
| Total liabilitiesA$ | 2,496,890 | 6,548,463 | 4,945,089 | 6,644,086 | 2,682,205 |
| Issued capitalA$ | 71,376,018 | 113,950,491 | 175,912,716 | 225,509,442 | 295,615,814 |
| ReservesA$ | 1,543,710 | 6,411,395 | 10,205,298 | 10,386,157 | 10,825,399 |
| Accumulated lossesA$ | (36,628,347) | (46,282,167) | (57,274,788) | (65,949,659) | (77,803,950) |
| Total equity (= net assets)A$ | 36,291,381 | 74,079,719 | 128,843,226 | 169,945,940 | 228,637,263 |
Balance-sheet issued capital is a net carrying amount; see the gross issued-capital movement schedule under Funding and capital structure.
Basis and presentation notes (7)
- Right of use liabilities (current) / FY2021 — Not separately presented: Right of use liabilities (current) is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R001856 supports a distinct FY2023 observation, not this target period.
- Right of use liabilities (current) / FY2022 — 0 (nil): Issuer reported a dash or nil for this line.
- Right of use liabilities (current) / FY2025 — 0 (nil): Issuer reported a dash or nil for this line.
- Advance from FX provider / FY2021 — Not separately presented: Advance from FX provider is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R002845 supports a distinct FY2024 observation, not this target period.
- Advance from FX provider / FY2022 — Not separately presented: Advance from FX provider is not separately resolved in the selected FY2022 statement. No nil value or issuer non-disclosure is inferred. R002845 supports a distinct FY2024 observation, not this target period.
- Advance from FX provider / FY2023 — Not separately presented: Advance from FX provider is not separately resolved in the selected FY2023 statement. No nil value or issuer non-disclosure is inferred. R002845 supports a distinct FY2024 observation, not this target period.
- Advance from FX provider / FY2025 — 0 (nil): Issuer reported a dash or nil for this line.
Source: Predictive Discovery annual reports for the stated years; each cell retains its frozen extraction or selected table row in the author evidence.
FINANCIAL REVIEW / 03
Cash use and funding flows
The FY2024 move of exploration payments to investing activities changes the meaning of the operating and investing subtotals. Read the component rows alongside those subtotals; the change is a statement classification, not a disappearance of exploration spending.
Net financing cash inflow
A$
Net cash from financing activities
AI-generated presentation · values from Consolidated cash-flow subtotals and cash bridge; no missing values plotted as zero.
Consolidated cash-flow subtotals and cash bridge
A$ unless a row specifies another unit
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net cash from operating activitiesA$ | (14,287,908) | (23,042,362) | (56,936,056) | (5,168,361) | (8,674,334) |
| Net cash from investing activitiesA$ | (347,181) | (712,097) | (453,666) | (59,251,069) | (47,490,901) |
| Net cash from financing activitiesA$ | 28,725,243 | 43,060,831 | 60,668,385 | 48,875,351 | 67,879,096 |
| Net increase (decrease) in cash heldA$ | 14,090,154 | 19,306,372 | 3,278,663 | (15,544,079) | 11,713,861 |
| Foreign exchange differences on cashA$ | 0 (nil) | 0 (nil) | (419,646) | 83,693 | 62,008 |
| Cash and cash equivalents at beginning of periodA$ | 8,639,015 | 22,729,169 | 42,035,541 | 44,894,558 | 29,434,172 |
| Cash and cash equivalents at end of periodA$ | 22,729,169 | 42,035,541 | 44,894,558 | 29,434,172 | 41,210,041 |
Exploration payments were operating cash flows in FY2021-FY2023 and investing cash flows in FY2024-FY2025.
Basis and presentation notes (2)
- Foreign exchange differences on cash / FY2021 — 0 (nil): Issuer reported a dash or nil for this line.
- Foreign exchange differences on cash / FY2022 — 0 (nil): Issuer reported a dash or nil for this line.
Source: Predictive Discovery annual reports for the stated years; each cell retains its frozen extraction or selected table row in the author evidence.
Selected operating, investing and financing cash-flow lines
A$ unless a row specifies another unit
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Interest receivedA$ | 4,865 | 3,113 | 632,838 | 1,223,463 | 2,034,945 |
| Government grant receivedA$ | 15,037 | 0 (nil) | 0 (nil) | Not separately presented | Not separately presented |
| Other income (operating)A$ | Not separately presented | Not separately presented | Not separately presented | 53,351 | 0 (nil) |
| Payments to suppliers and employeesA$ | (1,645,956) | (1,665,208) | (4,925,324) | (6,858,175) | (11,634,612) |
| GST receivedA$ | Not separately presented | Not separately presented | Not separately presented | 413,000 | 925,333 |
| Payments for exploration expenditureA$ | (12,661,854) | (21,380,268) | (52,643,570) | (36,104,723) | (42,070,616) |
| Purchase of property, plant and equipmentA$ | (347,181) | (712,097) | (493,844) | (146,346) | (400,285) |
| Disposal of property, plant and equipmentA$ | Not separately presented | 0 (nil) | 40,178 | 0 (nil) | Not separately presented |
| Payment for other financial assetsA$ | Not separately presented | Not separately presented | Not separately presented | (23,000,000) | (5,020,000) |
| Advance share subscription proceedsA$ | 0 (nil) | 498,391 | 0 (nil) | Not separately presented | Not separately presented |
| Proceeds from issue of sharesA$ | 30,563,590 | 44,043,679 | 60,727,646 | 50,150,000 | 69,243,012 |
| Proceeds on exercise of optionsA$ | 32,394 | 848,108 | 3,005,858 | 1,801,100 | 560,000 |
| Payment for share issue costsA$ | (1,870,741) | (2,329,347) | (3,065,119) | (2,921,834) | (1,764,589) |
| Payments for leasesA$ | Not separately presented | Not separately presented | Not separately presented | (153,914) | (159,327) |
Exploration payments cross statement categories after FY2023; the row shows the issuer's cash expenditure, with the classification break noted above.
Other financial assets are labelled as such in the cash-flow statement; the separate balance-sheet note identifies the year-end term-deposit balances.
FY2022 includes A$498,391 advance share subscription proceeds, distinct from ordinary share proceeds and option exercises.
Basis and presentation notes (25)
- Government grant received / FY2022 — 0 (nil): Issuer reported a dash or nil for this line.
- Government grant received / FY2023 — 0 (nil): Issuer reported a dash or nil for this line.
- Government grant received / FY2024 — Not separately presented: Government grant received is not separately resolved in the selected FY2024 statement. No nil value or issuer non-disclosure is inferred. R000282 supports a distinct FY2021 observation, not this target period.
- Government grant received / FY2025 — Not separately presented: Government grant received is not separately resolved in the selected FY2025 statement. No nil value or issuer non-disclosure is inferred. R000282 supports a distinct FY2021 observation, not this target period.
- Other income (operating) / FY2021 — Not separately presented: Other income (operating) is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R002865 supports a distinct FY2024 observation, not this target period.
- Other income (operating) / FY2022 — Not separately presented: Other income (operating) is not separately resolved in the selected FY2022 statement. No nil value or issuer non-disclosure is inferred. R002865 supports a distinct FY2024 observation, not this target period.
- Other income (operating) / FY2023 — Not separately presented: Other income (operating) is not separately resolved in the selected FY2023 statement. No nil value or issuer non-disclosure is inferred. R002865 supports a distinct FY2024 observation, not this target period.
- Other income (operating) / FY2025 — 0 (nil): Issuer reported a dash or nil for this line.
- GST received / FY2021 — Not separately presented: GST received is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R002869 supports a distinct FY2024 observation, not this target period.
- GST received / FY2022 — Not separately presented: GST received is not separately resolved in the selected FY2022 statement. No nil value or issuer non-disclosure is inferred. R002869 supports a distinct FY2024 observation, not this target period.
- GST received / FY2023 — Not separately presented: GST received is not separately resolved in the selected FY2023 statement. No nil value or issuer non-disclosure is inferred. R002869 supports a distinct FY2024 observation, not this target period.
- Disposal of property, plant and equipment / FY2021 — Not separately presented: Disposal of property, plant and equipment is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R001884 supports a distinct FY2023 observation, not this target period.
- Disposal of property, plant and equipment / FY2022 — 0 (nil): Issuer reported a dash or nil for this line.
- Disposal of property, plant and equipment / FY2024 — 0 (nil): Issuer reported a dash or nil for this line.
- Disposal of property, plant and equipment / FY2025 — Not separately presented: Disposal of property, plant and equipment is not separately resolved in the selected FY2025 statement. No nil value or issuer non-disclosure is inferred. R001885 supports a distinct FY2022 observation, not this target period.
- Payment for other financial assets / FY2021 — Not separately presented: Payment for other financial assets is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R002873 supports a distinct FY2024 observation, not this target period.
- Payment for other financial assets / FY2022 — Not separately presented: Payment for other financial assets is not separately resolved in the selected FY2022 statement. No nil value or issuer non-disclosure is inferred. R002873 supports a distinct FY2024 observation, not this target period.
- Payment for other financial assets / FY2023 — Not separately presented: Payment for other financial assets is not separately resolved in the selected FY2023 statement. No nil value or issuer non-disclosure is inferred. R002873 supports a distinct FY2024 observation, not this target period.
- Advance share subscription proceeds / FY2021 — 0 (nil): Issuer reported a dash or nil for this line.
- Advance share subscription proceeds / FY2023 — 0 (nil): Issuer reported a dash or nil for this line.
- Advance share subscription proceeds / FY2024 — Not separately presented: Advance share subscription proceeds is not separately resolved in the selected FY2024 statement. No nil value or issuer non-disclosure is inferred. R001032 supports a distinct FY2021 observation, not this target period.
- Advance share subscription proceeds / FY2025 — Not separately presented: Advance share subscription proceeds is not separately resolved in the selected FY2025 statement. No nil value or issuer non-disclosure is inferred. R001032 supports a distinct FY2021 observation, not this target period.
- Payments for leases / FY2021 — Not separately presented: Payments for leases is not separately resolved in the selected FY2021 statement. No nil value or issuer non-disclosure is inferred. R002889 supports a distinct FY2024 observation, not this target period.
- Payments for leases / FY2022 — Not separately presented: Payments for leases is not separately resolved in the selected FY2022 statement. No nil value or issuer non-disclosure is inferred. R002889 supports a distinct FY2024 observation, not this target period.
- Payments for leases / FY2023 — Not separately presented: Payments for leases is not separately resolved in the selected FY2023 statement. No nil value or issuer non-disclosure is inferred. R002889 supports a distinct FY2024 observation, not this target period.
Source: Predictive Discovery annual reports for the stated years; each cell retains its frozen extraction or selected table row in the author evidence.
FINANCIAL REVIEW / 04
Funding and capital structure
Ordinary shares on issue increased across the five balance dates. The gross issued-capital movement schedule and the net balance-sheet issued-capital amount use different cost presentations; each is labelled in its own table.
No dividends were paid or declared in the FY2022 and FY2025 annual disclosures. The report does not convert this into a shareholder-return estimate.
Ordinary shares on issue
shares
Ordinary shares on issue (closing balance)
AI-generated presentation · values from Ordinary shares and gross issued capital; no missing values plotted as zero.
FINANCIAL REVIEW / 05
Bankan project evidence and study economics
The Resource snapshots are dated milestones, not five balance-sheet figures. The FY2025 total includes the Argo area, so its boundary differs from the earlier NE Bankan and Bankan Creek totals. Resource and Reserve estimates are distinct classifications and should not be added together.
The PFS Extension Case and DFS base case use different gold-price assumptions for their post-tax NPV and IRR figures: US$1,800/oz and US$2,400/oz respectively. The PFS Extension production profile includes 12.8% Inferred Mineral Resources and the DFS profile includes 9.4%; neither equals the Ore Reserve boundary. The figures are issuer project-study scenarios rather than historical revenue, realised margin or a valuation of the company.
The FY2025 report records a May 2025 Guinea permit-revocation notice concerning Argo and Bokoro; directors considered the exploration expenditure recoverable and said they intended to appeal. An October 2025 merger announcement with Robex was subsequent to the June balance date. These are dated issuer positions, not later status updates.
Dated Bankan Mineral Resource milestones
Metric-specific
| Metric | Sep 2021 | Aug 2022 | Aug 2023 | 30 Jun 2025 |
|---|---|---|---|---|
| Bankan Mineral Resource tonnesMt | 72.8 | 79.5 | 100.5 | 103.6 |
| Average gold gradeg/t | 1.56 | 1.63 | 1.66 | 1.66 |
| Contained goldkoz | 3,646 | 4,215 | 5,376 | 5,528 |
September 2021 followed the FY2021 balance date; August 2022 and August 2023 are subsequent project estimates, not FY2022/FY2023 closing financial balances.
FY2025 includes the Argo area as well as the NE Bankan area; earlier totals refer to NE Bankan and Bankan Creek. Figures follow each issuer snapshot without forced like-for-like adjustment.
Source: Predictive Discovery annual reports for the stated years; each cell retains its frozen extraction or selected table row in the author evidence.
Bankan Probable Ore Reserves
Metric-specific
| Metric | Apr 2024 PFS | 30 Jun 2025 DFS |
|---|---|---|
| Probable Ore Reserve tonnesMt | 57.7 | 51.6 |
| Ore Reserve gradeg/t | 1.64 | 1.78 |
| Contained gold in Ore Reserveskoz | 3,047 | 2,953 |
Ore Reserve totals are JORC Probable estimates. The DFS production profile of 54.5Mt / 3,260koz includes 9.4% Inferred Mineral Resources and is therefore a different boundary from the 51.6Mt / 2,953koz Reserve table.
Source: Predictive Discovery annual reports for the stated years; each cell retains its frozen extraction or selected table row in the author evidence.
PFS Extension Case and DFS base-case project estimates
Metric-specific
| Metric | Apr 2024 PFS Extension Case | Jun 2025 DFS base case |
|---|---|---|
| Mine Lifeyears | 12 | 12 years 2 months |
| Processing RateMtpa | 5.5 | 4.5 |
| Avg Processing Recovery% | 92.4 | 92.8 |
| Avg Gold Productionkoz/year | 269 | 249 |
| C1 Cash Costs (LOM)US$/oz | 968 | 841 |
| AISC (LOM)US$/oz | 1,131 | 1,057 |
| Pre-production CapitalUS$m | 456 | 463 |
| Post-tax NPV5%US$m | 668 | 1,637 |
| Post-tax IRR% | 25.4 | 46 |
PFS Extension Case post-tax NPV and IRR use US$1,800/oz gold; DFS base case uses US$2,400/oz. They are not a like-for-like improvement series.
The PFS Extension Case production profile includes 12.8% Inferred Mineral Resources; the DFS profile includes 9.4% Inferred. Neither profile is identical to the Ore Reserve totals.
AISC and C1 are prospective non-IFRS life-of-mine estimates. Pre-production capital is an estimate, not historical capital spent.
DFS production-profile tonnage includes an Inferred Resource component and is distinct from Ore Reserves.
The DFS mine life is stated as 12 years 2 months (R004678); the exact issuer wording is retained rather than converted to a rounded decimal year.
Basis and presentation notes (1)
- Mine Life / Jun 2025 DFS base case — 12 years 2 months: Issuer-stated textual measure; no artificial decimal conversion.
Source: Predictive Discovery annual reports for the stated years; each cell retains its frozen extraction or selected table row in the author evidence.
Reading the figures
- This report is based on the five frozen annual extraction packages and selected same-issuer annual table rows, without a fresh raw-document or PDF review.
- Current-year and later comparative presentation differ for part of the FY2023 result. Original-year values are displayed unless explicitly labelled otherwise.
- A not-separately-presented cell is not a statement that the issuer never disclosed the measure elsewhere.
Annual-report source registry
- Predictive Discovery Limited annual report 2021Year ended 2021-06-30; report dated 2021-10-29.
- Predictive Discovery Limited annual report 2022Year ended 2022-06-30; report dated 2022-10-18.
- Predictive Discovery Limited annual report 2023Year ended 2023-06-30; report dated 2023-10-13.
- Predictive Discovery Limited annual report 2024Year ended 2024-06-30; report dated 2024-10-18.
- Predictive Discovery Limited annual report 2025Year ended 2025-06-30; report dated 2025-10-27.
Prepared from the existing annual extraction datasets, supplemented only by selected same-company annual-report tables and saved row interpretations. No new raw-document extraction or web financial research was used for this test.
Sources, copyright and independence
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
AI-led method
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
Information notice
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.